The American Civil Liberties Union of Utah has pushed back on the U.S. Drug Enforcement Administration's attempts to access the state's prescription drug database without probable cause.
The head of the National Institute of Allergy and Infectious Diseases said Friday that preparations for the second phase of vaccine testing may be impossible without more money, which will be difficult to obtain with Congress on a weeks-long break.
The Federal Trade Commission ruled Friday that a clinical laboratory's lax data security practices violated federal law – a decision that some say could mean tougher enforcement for healthcare providers.
The American Medical Association has partnered with Intermountain Healthcare and a health information technology firm in an effort to use digital health services to prevent Type 2 diabetes.
LifePoint Health reported a net income drop in the second quarter of almost 60% to $20.1 million. The hospital chain's CEO said the lion's share of the earnings miss was caused by the abrupt departure of several physicians at an undisclosed hospital.
University of Minnesota Physicians has begun steps to re-evaluate its strategic vision shortly after plans to acquire Fairview Health Services were terminated.
The expansion of a group purchasing organization serving the public health sector and the recent launch of similar organizations reflect new demands from providers who are faced with an increasingly consolidated GPO market, experts say.
Virtual reality, a Chicago doctor explains, exposes veterans to the sights, sounds, sensations and even scents of the events responsible for their trauma: a shooting, an attack, an IED explosion. Exposure to the trauma in a safe, controlled setting can help retrain brains to overcome fear.
If transmission within the U.S. spreads, providers serving populations that have been identified as being the most vulnerable say they might not be ready as they face reductions in disproportionate-share payments.
A federal judge in New York threw out nearly 1,300 lawsuits against Bayer over its Mirena intrauterine contraceptive device. The judge excluded expert testimony, feeling it would have been biased.